Section Arrow
ETON.NASDAQ
- Eton Pharmaceuticals
Quotes are at least 15-min delayed:2025/05/10 17:33 EDT
Last
 16.79
-0.54 (-3.12%)
Day High 
17.74 
Prev. Close
17.33 
1-M High
17.5991 
Volume 
167.31K 
Bid
16
Ask
17.95
Day Low
16.77 
Open
17.47 
1-M Low
11.09 
Market Cap 
464.75M 
Currency USD 
P/E 124 
%Yield -- 
10-SMA 16.76 
20-SMA 15.45 
50-SMA 14.58 
52-W High 18.405 
52-W Low 3.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.15/1.57
Enterprise Value
494.67M
Balance Sheet
Book Value Per Share
0.91
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
39.01M
Operating Revenue Per Share
1.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc0.2325-0.0375-13.89%-- 
PTPIPetros Pharmaceuticals Inc0.1201-0.0053-4.23%-- 
VTRSViatris8.77-0.32-3.52%227.2PE
TEVATeva Pharmaceutical Industries Limited16.93-1.14-6.31%-- 
IXHLIncannex Healthcare0.1135+0.0009+0.80%-- 
Quotes are at least 15-min delayed:2025/05/10 17:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.